Correction: SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction: SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021 ; volume:23 ; number:1 ; day:27 ; month:1 ; year:2023 ; pages:1 ; date:12.2023
BMC public health ; 23, Heft 1 (27.1.2023), 1, 12.2023
- Creator
-
Konu, Yao Rodion
Condé, Siaka
Gbeasor-Komlanvi, Fifonsi
Sadio, Arnold Junior
Tchankoni, Martin Kouame
Anani, Joel
Bitty-Anderson, Alexandra
Mirindi, Bisimwa Ruhana
Diallo, Fatoumata Binta Tidiane
MIjiyawa, Moustapha
Dagnra, Anoumou Claver
Ekouevi, Didier Koumavi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-023-15004-3
- URN
-
urn:nbn:de:101:1-2023040321390718014924
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Konu, Yao Rodion
- Condé, Siaka
- Gbeasor-Komlanvi, Fifonsi
- Sadio, Arnold Junior
- Tchankoni, Martin Kouame
- Anani, Joel
- Bitty-Anderson, Alexandra
- Mirindi, Bisimwa Ruhana
- Diallo, Fatoumata Binta Tidiane
- MIjiyawa, Moustapha
- Dagnra, Anoumou Claver
- Ekouevi, Didier Koumavi
- SpringerLink (Online service)
Other Objects (12)
SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
Seroprevalence of SARS-CoV-2 antibodies in low-income university students
Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
Seroprevalence of SARS-CoV-2 antibodies in low-income university students
Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
Seroprevalence of SARS-CoV-2 antibodies in low-income university students